tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
Premium
Company Announcements
Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
2M ago
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
Premium
The Fly
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
2M ago
Precigen price target raised to $8 from $6 at Citizens JMP
PremiumThe FlyPrecigen price target raised to $8 from $6 at Citizens JMP
4M ago
Precigen Enters Commercial Supply Agreement with Catalent
Premium
Company Announcements
Precigen Enters Commercial Supply Agreement with Catalent
4M ago
Unusually active option classes on open August 18th
Premium
The Fly
Unusually active option classes on open August 18th
4M ago
Morning Movers: Precigen surges following full FDA approval of Papzimeos
PremiumThe FlyMorning Movers: Precigen surges following full FDA approval of Papzimeos
4M ago
Video: UnitedHealth jumps after Berkshire buy, Target slips after downgrade
Premium
The Fly
Video: UnitedHealth jumps after Berkshire buy, Target slips after downgrade
4M ago
Precigen price target raised to $8.50 from $6 at H.C. Wainwright
Premium
The Fly
Precigen price target raised to $8.50 from $6 at H.C. Wainwright
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100